Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.
von Weizsäcker
F
F
Department of Medicine II, University Hospital, Freiburg, Germany.
Wieland
S
S
Köck
J
J
Offensperger
W B
WB
Offensperger
S
S
Moradpour
D
D
Blum
H E
HE
D015316:Genetic Therapy; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D006801:Humans; D009154:Mutation; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D016337:RNA, Catalytic / Q000627:therapeutic use*; D014762:Viral Interference
D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic